United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

UTHR is expected to report earnings to rise 5.49% to $6.53 per share on April 30

United Therapeutics UTHR Stock Earnings Reports

Q1'25

Est.

$6.53

Q4'24

Missed

by $0.49

Q3'24

Missed

by $0.14

Q2'24

Missed

by $0.63

Q1'24

Beat

by $0.38

The last earnings report on February 26 showed earnings per share of $6.19, missing the estimate of $6.68. With 431.93K shares outstanding, the current market capitalization sits at 13.80B.

View a ticker or compare two or three

Compare

UTHR